Previous close | 2.2000 |
Open | 3.7000 |
Bid | 0.0500 |
Ask | 2.5000 |
Strike | 12.50 |
Expiry date | 2024-08-16 |
Day's range | 1.3000 - 3.7000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Performance Analysis and Future Clinical Prospects
BOULDER, Colo., May 10, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024, at 3:35 pm ET.
BOULDER, Colo., May 09, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights.